The Cochrane Library

1 MeSH descriptor: [Prostatic Neoplasms] explode all trees 2 (prostat* near (cancer* or tumo* or neoplas* or carcinom* or malign*)) 3 (#1 or #2) 4 (LHRH antagonist* or LH RH antagonist* or GNRH antagonist* or GN RH antagonist*) 5 (FE200486* or FE 200486*) 6 (firmagon* or degarelix*) 7 (#4 or #5 or #6) 8 (#3 and #7)

MEDLINE (via OvidSP)

1 Prostatic Neoplasms/ 2 (prostat* adj3 (cancer* or tumo* or neoplas* or carcinom* or malign*)).tw. 3 1 or 2 4 (LHRH antagonist* or LH RH antagonist* or GNRH antagonist* or GN RH antagonist*).tw. 5 (FE200486* or FE 200486*).mp. 6 (firmagon* or degarelix*).mp. 7 4 or 5 or 6 8 3 and 7

Web of Science (Clarivate Analytics)

1 TS=(prostat* same (cancer* or tumo* or neoplas* or carcinom* or malign*)) 2 TS=((LHRH same antagonist*) or (LH same RH same antagonist*)) 3 TS=((gnrh same antagonist*) OR (gn same rh same antagonist*)) 4 TS=(FE200486*) 5 TS=(FE same 200486*) 6 TS=(firmagon* OR degarelix*) 7 #6 OR #5 OR #4 OR #3 OR #2 8 #7 AND #1

Trial registers: ClinicalTrials.gov, World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal

Keywords: ‘degarelix’, ‘firmagon’, 'FE200486', 'FE 200486'

Scopus

degarelix OR firmagon OR FE200486 OR FE 200486

LILACS

Keywords: ‘degarelix’, ‘firmagon’, 'FE200486', 'FE 200486'

Embase (via OvidSP)

1 exp prostate tumor/ 2 (prostat* adj3 (cancer* or tumo* or neoplas* or carcinoma* or malign*)).tw. 3 1 or 2 4 exp gonadorelin antagonist/ 5 (LHRH antagonist* or LH RH antagonist or GNRH antagonist* or GN RH antagonist*).tw. 6 (FE200486* or FE 200486*).tw. 7 (firmagon* or degarelix*).tw. 8 4 or 5 or 6 or 7 9 3 and 8